J&J(US:JNJ) Yahoo Finance·2025-12-19 07:57Core Insights - Not every stock requires a high-growth narrative to outperform; consistency in execution is key for long-term success [1] - In 2025, certain companies are achieving significant year-to-date gains while providing reliable income, characterized by strong management and resilience across market cycles [1] Dividend Kings - The focus is on identifying Dividend Kings, which are companies that have increased their dividends for over 50 consecutive years, emphasizing long-term value and near-term momentum based on 2025 performance [2] - The selection process involved using Barchart's Stock Screener with specific filters to identify stocks with strong year-to-date performance [3][4] Johnson & Johnson (JNJ) - Johnson & Johnson is a major player in the healthcare sector, known for a wide range of pharmaceutical products and consumer brands [5] - The company reported a year-over-year sales increase of 7% to $24 billion and a net income growth of over 90% to $5.2 billion [6] - JNJ's stock has risen over 45% year-to-date, making it the top-performing Dividend King in 2025 [6]